{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T13:16:29Z","timestamp":1788009389201,"version":"build-2784847793"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T00:00:00Z","timestamp":1787961600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T00:00:00Z","timestamp":1787961600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP23K06438"],"award-info":[{"award-number":["JP23K06438"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007449","name":"Takeda Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007449","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the Foundation for Promotion of Cancer Research"},{"DOI":"10.13039\/501100003837","name":"Ichiro Kanehara Foundation for the Promotion of Medical Sciences and Medical Care","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003837","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Head and Neck Pathol"],"DOI":"10.1007\/s12105-026-01960-w","type":"journal-article","created":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T12:50:58Z","timestamp":1788007858000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Inflammatory Rhabdomyoblastic Tumor with Malignant Progression of the Neck: Unique Copy Number Profile Identified by Nanopore Sequencing"],"prefix":"10.1007","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-3424-6684","authenticated-orcid":false,"given":"Kengo","family":"Shiraishi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6991-747X","authenticated-orcid":false,"given":"Naohiro","family":"Makise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryuta","family":"Kojima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsukasa","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiko","family":"Odaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariko","family":"Oikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Amano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akinobu","family":"Araki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sawato","family":"Fukuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukiyoshi","family":"Mita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ichiro","family":"Fukumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Kinoshita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahito","family":"Kawazu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toyoyuki","family":"Hanazawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,29]]},"reference":[{"issue":"2","key":"1960_CR1","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/s00428-020-02774-z","volume":"477","author":"M Michal","year":"2020","unstructured":"Michal M, Rubin BP, Kazakov DV et al (2020) Inflammatory leiomyosarcoma shows frequent co-expression of smooth and skeletal muscle markers supporting a primitive myogenic phenotype: a report of 9 cases with a proposal for reclassification as low-grade inflammatory myogenic tumor. Virchows Arch 477(2):219\u2013230. https:\/\/doi.org\/10.1007\/s00428-020-02774-z","journal-title":"Virchows Arch"},{"issue":"4","key":"1960_CR2","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1038\/s41379-020-00703-8","volume":"34","author":"JM Cloutier","year":"2021","unstructured":"Cloutier JM, Charville GW, Mertens F et al (2021) \u201cInflammatory leiomyosarcoma\u201d and \u201chistiocyte-rich rhabdomyoblastic tumor\u201d: a clinicopathological, immunohistochemical and genetic study of 13 cases, with a proposal for reclassification as \"inflammatory rhabdomyoblastic tumor. Mod Pathol 34(4):758\u2013769. https:\/\/doi.org\/10.1038\/s41379-020-00703-8","journal-title":"Mod Pathol"},{"issue":"4","key":"1960_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.semdp.2025.150917","volume":"42","author":"AL Folpe","year":"2025","unstructured":"Folpe AL (2025) Inflammatory rhabdomyoblastic tumor: a review and update. Semin Diagn Pathol 42(4):150917. https:\/\/doi.org\/10.1016\/j.semdp.2025.150917","journal-title":"Semin Diagn Pathol"},{"issue":"1","key":"1960_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.modpat.2023.100359","volume":"37","author":"T Odate","year":"2024","unstructured":"Odate T, Satomi K, Kubo T et al (2024) Inflammatory rhabdomyoblastic tumor: clinicopathologic and molecular analysis of 13 cases. Mod Pathol 37(1):100359. https:\/\/doi.org\/10.1016\/j.modpat.2023.100359","journal-title":"Mod Pathol"},{"issue":"6","key":"1960_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.modpat.2023.100131","volume":"36","author":"CA Dehner","year":"2023","unstructured":"Dehner CA, Geiersbach K, Rowsey R et al (2023) Rhabdomyosarcoma arising in inflammatory rhabdomyoblastic tumor: a genetically distinctive subtype of rhabdomyosarcoma. Mod Pathol 36(6):100131. https:\/\/doi.org\/10.1016\/j.modpat.2023.100131","journal-title":"Mod Pathol"},{"issue":"5","key":"1960_CR6","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1038\/s41379-021-00791-0","volume":"34","author":"K Geiersbach","year":"2021","unstructured":"Geiersbach K, Kleven DT, Blankenship HT et al (2021) Inflammatory rhabdomyoblastic tumor with progression to high-grade rhabdomyosarcoma. Mod Pathol 34(5):1035\u20131036. https:\/\/doi.org\/10.1038\/s41379-021-00791-0","journal-title":"Mod Pathol"},{"issue":"10","key":"1960_CR7","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1111\/pin.13468","volume":"74","author":"N Makise","year":"2024","unstructured":"Makise N, Lin J, Kageyama H et al (2024) Fluorescence in situ hybridization-negative intra-articular myxoid liposarcoma with complex rearrangements involving EWSR1::DDIT3 detected using nanopore sequencing. Pathol Int 74(10):604\u2013610. https:\/\/doi.org\/10.1111\/pin.13468","journal-title":"Pathol Int"},{"issue":"7","key":"1960_CR8","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1056\/NEJMc2201810","volume":"387","author":"S Wei","year":"2022","unstructured":"Wei S, Djandji A, Lattin MT et al (2022) Rapid Nanopore sequencing-based screen for aneuploidy in reproductive care. N Engl J Med 387(7):658\u2013660. https:\/\/doi.org\/10.1056\/NEJMc2201810","journal-title":"N Engl J Med"},{"issue":"1","key":"1960_CR9","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1038\/s41467-020-20603-4","volume":"12","author":"C Koelsche","year":"2021","unstructured":"Koelsche C, Schrimpf D, Stichel D et al (2021) Sarcoma classification by DNA methylation profiling. Nat Commun 12(1):498. https:\/\/doi.org\/10.1038\/s41467-020-20603-4","journal-title":"Nat Commun"},{"issue":"23","key":"1960_CR10","doi-asserted-by":"publisher","first-page":"4572","DOI":"10.1093\/bioinformatics\/btab705","volume":"37","author":"H Li","year":"2021","unstructured":"Li H (2021) New strategies to improve minimap2 alignment accuracy. Bioinformatics 37(23):4572\u20134574. https:\/\/doi.org\/10.1093\/bioinformatics\/btab705","journal-title":"Bioinformatics"},{"key":"1960_CR11","unstructured":"Oxford Nanopore Technologies (2023) Reduced-representation methylation sequencing (RRMS) captures 100% of CpG islands and more. https:\/\/nanoporetech.com\/api\/assets\/f\/196663\/735a4dd4c9\/j2127_a1-poster_rrms-v3_digital.pdf. Accessed 24 Jun 2026"},{"issue":"12","key":"1960_CR12","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1101\/gr.175141.114","volume":"24","author":"I Scheinin","year":"2014","unstructured":"Scheinin I, Sie D, Bengtsson H et al (2014) DNA copy number analysis of fresh and formalin-fixed specimens by shallow whole-genome sequencing with identification and exclusion of problematic regions in the genome assembly. Genome Res 24(12):2022\u20132032. https:\/\/doi.org\/10.1101\/gr.175141.114","journal-title":"Genome Res"},{"issue":"6","key":"1960_CR13","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1111\/j.1365-2559.1995.tb00323.x","volume":"27","author":"W Merchant","year":"1995","unstructured":"Merchant W, Calonje E, Fletcher CD (1995) Inflammatory leiomyosarcoma: a morphological subgroup within the heterogeneous family of so-called inflammatory malignant fibrous histiocytoma. Histopathology 27(6):525\u2013532. https:\/\/doi.org\/10.1111\/j.1365-2559.1995.tb00323.x","journal-title":"Histopathology"},{"issue":"3","key":"1960_CR14","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/s41379-018-0145-0","volume":"32","author":"AP Martinez","year":"2019","unstructured":"Martinez AP, Fritchie KJ, Weiss SW et al (2019) Histiocyte-rich rhabdomyoblastic tumor: rhabdomyosarcoma, rhabdomyoma, or rhabdomyoblastic tumor of uncertain malignant potential? A histologically distinctive rhabdomyoblastic tumor in search of a place in the classification of skeletal muscle neoplasms. Mod Pathol 32(3):446\u2013457. https:\/\/doi.org\/10.1038\/s41379-018-0145-0","journal-title":"Mod Pathol"},{"issue":"1","key":"1960_CR15","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/modpathol.2017.113","volume":"31","author":"E Arbajian","year":"2018","unstructured":"Arbajian E, K\u00f6ster J, von Steyern FV et al (2018) Inflammatory leiomyosarcoma is a distinct tumor characterized by near-haploidization, few somatic mutations, and a primitive myogenic gene expression signature. Mod Pathol 31(1):93\u2013100. https:\/\/doi.org\/10.1038\/modpathol.2017.113","journal-title":"Mod Pathol"},{"key":"1960_CR16","unstructured":"WHO Classification of Tumours Editorial Board (2020) Soft Tissue and Bone Tumours. 5th edn. International Agency for Research on Cancer, Lyon"},{"issue":"11","key":"1960_CR17","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1002\/gcc.23072","volume":"61","author":"M Sukhanova","year":"2022","unstructured":"Sukhanova M, Obeidin F, Streich L et al (2022) Inflammatory leiomyosarcoma\/rhabdomyoblastic tumor: a report of two cases with novel genetic findings. Genes Chromosomes Cancer 61(11):653\u2013661. https:\/\/doi.org\/10.1002\/gcc.23072","journal-title":"Genes Chromosomes Cancer"},{"key":"1960_CR18","doi-asserted-by":"publisher","first-page":"1489754","DOI":"10.3389\/fped.2025.1489754","volume":"13","author":"MS Nadhirah","year":"2025","unstructured":"Nadhirah MS, Hamidah A, Harizah AAA et al (2025) Case Report: First case of a pediatric laryngeal inflammatory rhabdomyoblastic tumor-diagnostic dilemma and insights into the conservative management of a residual lesion. Front Pediatr 13:1489754. https:\/\/doi.org\/10.3389\/fped.2025.1489754","journal-title":"Front Pediatr"},{"issue":"2","key":"1960_CR19","doi-asserted-by":"publisher","first-page":"154","DOI":"10.5146\/tjpath.2022.01577","volume":"39","author":"B Rekhi","year":"2023","unstructured":"Rekhi B, Bal M, Dharavath B et al (2023) A rare case of a low-grade inflammatory leiomyosarcoma\/histiocyte-rich rhabdomyoblastic tumor in the neck of an adolescent male. Turk Patoloji Derg 39(2):154\u2013160. https:\/\/doi.org\/10.5146\/tjpath.2022.01577","journal-title":"Turk Patoloji Derg"},{"issue":"6","key":"1960_CR20","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.63399","volume":"16","author":"MM Alali","year":"2024","unstructured":"Alali MM, Aodah A (2024) Intraoral inflammatory leiomyosarcoma: a case report and literature review. Cureus 16(6):e63399. https:\/\/doi.org\/10.7759\/cureus.63399","journal-title":"Cureus"},{"key":"1960_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijscr.2021.105907","volume":"82","author":"N Viljoen","year":"2021","unstructured":"Viljoen N, Vilijoen G, Fagan JJ et al (2021) Inflammatory leiomyosarcoma of the head and neck: case report. Int J Surg Case Rep 82:105907. https:\/\/doi.org\/10.1016\/j.ijscr.2021.105907","journal-title":"Int J Surg Case Rep"},{"issue":"9","key":"1960_CR22","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1593\/neo.12930","volume":"14","author":"K Nord","year":"2012","unstructured":"Nord K, Paulsson K, Veerla S et al (2012) Retained heterodisomy is associated with high gene expression in hyperhaploid inflammatory leiomyosarcoma. Neoplasia 14(9):807\u2013812. https:\/\/doi.org\/10.1593\/neo.12930","journal-title":"Neoplasia"},{"issue":"1","key":"1960_CR23","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s12672-025-02189-9","volume":"16","author":"T Xu","year":"2025","unstructured":"Xu T, Luo S (2025) Histiocyte-rich rhabdomyoblastic tumor easily misdiagnosed as rhabdomyosarcoma: a case report. Discov Oncol 16(1):385. https:\/\/doi.org\/10.1007\/s12672-025-02189-9","journal-title":"Discov Oncol"},{"issue":"1","key":"1960_CR24","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s13000-024-01503-3","volume":"19","author":"O Jokelainen","year":"2024","unstructured":"Jokelainen O, Myllykangas H, Rajala K et al (2024) Inflammatory rhabdomyoblastic tumor, pheochromocytoma, and pulmonary hamartoma in a patient with neurofibromatosis type 1: a case report. Diagn Pathol 19(1):78. https:\/\/doi.org\/10.1186\/s13000-024-01503-3","journal-title":"Diagn Pathol"},{"issue":"7","key":"1960_CR25","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1038\/s41379-021-00797-8","volume":"34","author":"JC Lee","year":"2021","unstructured":"Lee JC, Li WS, Kao YC et al (2021) Toward a unifying entity that encompasses most, but perhaps not all, inflammatory leiomyosarcomas and histiocyte-rich rhabdomyoblastic tumors. Mod Pathol 34(7):1434\u20131438. https:\/\/doi.org\/10.1038\/s41379-021-00797-8","journal-title":"Mod Pathol"},{"issue":"2","key":"1960_CR26","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1053\/j.jfas.2005.12.010","volume":"45","author":"N Efstathopoulos","year":"2006","unstructured":"Efstathopoulos N, Lazarettos J, Nikolaou V et al (2006) Inflammatory leiomyosarcoma of the ankle: a case report and review of the literature. J Foot Ankle Surg 45(2):127\u2013130. https:\/\/doi.org\/10.1053\/j.jfas.2005.12.010","journal-title":"J Foot Ankle Surg"},{"issue":"1","key":"1960_CR27","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1078\/0344-0338-00351","volume":"199","author":"A Morovi\u0107","year":"2003","unstructured":"Morovi\u0107 A, Delcore R, Damjanov I (2003) Inflammatory leiomyosarcoma of the retroperitoneum. Pathol Res Pract 199(1):41\u201343. https:\/\/doi.org\/10.1078\/0344-0338-00351","journal-title":"Pathol Res Pract"},{"issue":"24","key":"1960_CR28","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000026105","volume":"100","author":"Y Xia","year":"2021","unstructured":"Xia Y, Li Y, Gong P et al (2021) Clinicopathological analysis and genomic profiling of a rare histiocyte-rich rhabdomyoblastic tumor: a case report. Medicine (Baltimore) 100(24):e26105. https:\/\/doi.org\/10.1097\/MD.0000000000026105","journal-title":"Medicine (Baltimore)"},{"issue":"10","key":"1960_CR29","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1016\/j.jdcr.2020.06.038","volume":"6","author":"MR Frizzell","year":"2020","unstructured":"Frizzell MR, Nguyen NM, Parikh SA et al (2020) Histiocyte-rich rhabdomyoblastic tumor of the trunk. JAAD Case Rep 6(10):1001\u20131002. https:\/\/doi.org\/10.1016\/j.jdcr.2020.06.038","journal-title":"JAAD Case Rep"},{"issue":"3","key":"1960_CR30","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1001\/jamaoto.2023.4350","volume":"150","author":"ER Baker","year":"2024","unstructured":"Baker ER, Allen MA, Jones RM et al (2024) Inflammatory rhabdomyoblastic tumor of the posterior pharyngeal wall. JAMA Otolaryngol Head Neck Surg 150(3):277\u2013278. https:\/\/doi.org\/10.1001\/jamaoto.2023.4350","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"1960_CR31","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s00428-020-02857-x","volume":"478","author":"M Bourgeau","year":"2021","unstructured":"Bourgeau M, Martinez AP (2021) Histiocyte-rich rhabdomyoblastic tumor: a report of two cases and a review of the differential diagnoses. Virchows Arch 478:367\u2013373. https:\/\/doi.org\/10.1007\/s00428-020-02857-x","journal-title":"Virchows Arch"},{"issue":"3","key":"1960_CR32","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1097\/PAS.0000000000001804","volume":"46","author":"YC Kao","year":"2022","unstructured":"Kao YC, Kuo CT, Kuo PY et al (2022) Pulmonary \u201cinflammatory leiomyosarcomas\u201d are indolent tumors with diploid genomes and no convincing rhabdomyoblastic differentiation. Am J Surg Pathol 46(3):424\u2013433. https:\/\/doi.org\/10.1097\/PAS.0000000000001804","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"1960_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s12890-023-02624-z","volume":"23","author":"T Shibayama","year":"2023","unstructured":"Shibayama T, Satomi K, Tanaka R et al (2023) Pulmonary inflammatory leiomyosarcoma represents a potential diagnostic pitfall of DNA methylation-based classification of sarcomas: a case report. BMC Pulm Med 23(1):324. https:\/\/doi.org\/10.1186\/s12890-023-02624-z","journal-title":"BMC Pulm Med"},{"issue":"1","key":"1960_CR34","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.path.2023.06.008","volume":"17","author":"M Michal","year":"2024","unstructured":"Michal M (2024) Inflammatory rhabdomyoblastic tumor: from a nebulous smooth muscle neoplasm to a novel skeletal muscle tumor subtype. Surg Pathol Clin 17(1):65\u201376. https:\/\/doi.org\/10.1016\/j.path.2023.06.008","journal-title":"Surg Pathol Clin"},{"issue":"5","key":"1960_CR35","doi-asserted-by":"publisher","DOI":"10.1002\/gcc.23238","volume":"63","author":"C Saoud","year":"2024","unstructured":"Saoud C, Dermawan JK, Sharma AE et al (2024) Genomic profiling of pleomorphic rhabdomyosarcoma reveals a genomic signature distinct from that of embryonal rhabdomyosarcoma. Genes Chromosom Cancer 63(5):e23238. https:\/\/doi.org\/10.1002\/gcc.23238","journal-title":"Genes Chromosom Cancer"},{"issue":"6","key":"1960_CR36","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s11864-015-0342-8","volume":"16","author":"C Ruiz-Mesa","year":"2015","unstructured":"Ruiz-Mesa C, Goldberg JM, Coronado Munoz AJ et al (2015) Rhabdomyosarcoma in adults: new perspectives on therapy. Curr Treat Options Oncol 16(6):27. https:\/\/doi.org\/10.1007\/s11864-015-0342-8","journal-title":"Curr Treat Options Oncol"},{"issue":"3","key":"1960_CR37","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.21873\/anticanres.13249","volume":"39","author":"YT Liu","year":"2019","unstructured":"Liu YT, Wang CW, Hong RL et al (2019) Prognostic factors and treatment outcomes of adult patients with rhabdomyosarcoma after multimodality treatment. Anticancer Res 39(3):1355\u20131364. https:\/\/doi.org\/10.21873\/anticanres.13249","journal-title":"Anticancer Res"},{"issue":"1","key":"1960_CR38","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1186\/s12885-020-6682-1","volume":"20","author":"H Shirasu","year":"2020","unstructured":"Shirasu H, Yokota T, Hamauchi S et al (2020) Risk factors for aspiration pneumonia during concurrent chemoradiotherapy or bio-radiotherapy for head and neck cancer. BMC Cancer 20(1):182. https:\/\/doi.org\/10.1186\/s12885-020-6682-1","journal-title":"BMC Cancer"}],"container-title":["Head and Neck Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12105-026-01960-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12105-026-01960-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12105-026-01960-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T12:51:00Z","timestamp":1788007860000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12105-026-01960-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,29]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1960"],"URL":"https:\/\/doi.org\/10.1007\/s12105-026-01960-w","relation":{},"ISSN":["1936-0568"],"issn-type":[{"value":"1936-0568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,29]]},"assertion":[{"value":"13 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Chiba Cancer Center Institutional Review Board (M04-005).","order":2,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"94"}}